Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors
10.1345/aph.1M241
Saved in:
Main Authors: | Eng, H.T., Chan, A. |
---|---|
Other Authors: | PHARMACY |
Format: | Review |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106651 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
by: De Lima Lopes Jr., G., et al.
Published: (2016) -
Cutaneous reaction associated with weekly docetaxel administration
by: Chew, L., et al.
Published: (2014) -
How well does the MESTT correlate with CTCAE scale for the grading of dermatological toxicities associated with oral tyrosine kinase inhibitors?
by: Chan, A., et al.
Published: (2014) -
Syntaxin 9 is enriched in skin hair follicle epithelium and interacts with the epidermal growth factor receptor
by: Wang, Y., et al.
Published: (2011) -
Identification of potentially useful combinations of epidermal growth factor receptor tyrosine kinase antagonists with conventional cytotoxic agents using median effect analysis
by: Budman, D.R., et al.
Published: (2014)